[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CO4900032A1 - Nuevos derivados de benzamidina - Google Patents

Nuevos derivados de benzamidina

Info

Publication number
CO4900032A1
CO4900032A1 CO97052335A CO97052335A CO4900032A1 CO 4900032 A1 CO4900032 A1 CO 4900032A1 CO 97052335 A CO97052335 A CO 97052335A CO 97052335 A CO97052335 A CO 97052335A CO 4900032 A1 CO4900032 A1 CO 4900032A1
Authority
CO
Colombia
Prior art keywords
unbranched
alkyl
branched
phenyl
mean
Prior art date
Application number
CO97052335A
Other languages
English (en)
Inventor
Kurt Schromm
Ralf Anderskewitz
Ernst-Otto Renth
Franz Birke
Hans Michael Jennewein
Meade Christopher John Montague
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of CO4900032A1 publication Critical patent/CO4900032A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/62—Compounds containing any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylcarbamates
    • C07C271/64—Y being a hydrogen or a carbon atom, e.g. benzoylcarbamates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Derivados de benzamidina de la fórmula general I en donde A puede significar -Oalquilen C2 -C4 O- o alquilen C1 -C3 O; R1 puede significar alquilo C1 -C6 , ramificado o no ramificado, alquenilo C3 -C6 ramificado o no ramificado, preferiblemente alilo o F, Cl, Br, I; R2 puede significar hidrógeno, alquilo C1 -C6 , ramificado o no ramificado, alquenilo C3 -C6 ramificado o no ramificado, preferiblemente alilo o F, Cl, Br, I; R3 y R4 que pueden ser iguales o diferentes, pueden significar, independientemente uno de otro hidrógeno, alquilo C1 -C6 , ramificado o no ramificado, alquenilo C3 -C6 ramificado o no ramificado, preferiblemente alilo, alcoxi C1 -C6 , (alquilo C1 -C4 ) OC (O) O-, OH o CF3 o juntos denotan un sistema de anillo monocíclico o bicíclico condensado que está completa o parcialmente conjugado y opcionalmente tiene uno o dos heteroátomos del grupo oxígeno, azufre o nitrógeno, que puede estar opcionalmente sustituido con OH, alcoxi C1 -C4 , alquilo C1 -C4 ; R5 puede significar hidrógeno, arilo, preferiblemente fenilo, ofenilo, -CR7 R8 fenilo, -C(O)fenilo, SO2 fenilo, CH(OH)fenilo, pudiendo estar sustituido el anillo de fenilo con OH, alcoxi C1 -C4 , o -C(O)NR9 R10 , R6 puede significar hidrógeno, alcoxi C1 -C6 carbonilo, (alquilo C1 -C5 )-carbonilo o -C(O) -O- (alquileno C1 -C6 ) -NR11 R12 ; R7 y R8 que pueden ser iguales o diferentes, pueden significar hidrógeno, alquilo C1 -C8 , ramificado o no ramificado o CF3 R9 y R10 que pueden ser iguales o diferentes, independientemente uno del otro pueden significar hidrógeno, alquilo C1 -C8 , ramificado o no ramificado; eventualmente en forma de los isómeros ópticos individuales, mezclas de los enantiómeros individuales o racematos, así como en forma de las bases libres o de las correspondientes sales por adición de ácidos con ácidos farmacológicamente inocuos.
CO97052335A 1996-09-10 1997-09-09 Nuevos derivados de benzamidina CO4900032A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19636689A DE19636689A1 (de) 1996-09-10 1996-09-10 Neue Benzamidinderivate

Publications (1)

Publication Number Publication Date
CO4900032A1 true CO4900032A1 (es) 2000-03-27

Family

ID=7805125

Family Applications (1)

Application Number Title Priority Date Filing Date
CO97052335A CO4900032A1 (es) 1996-09-10 1997-09-09 Nuevos derivados de benzamidina

Country Status (31)

Country Link
US (2) US6197824B1 (es)
EP (2) EP1203764B1 (es)
JP (2) JP4150427B2 (es)
KR (1) KR20000036005A (es)
CN (1) CN1104412C (es)
AR (1) AR009741A1 (es)
AT (2) ATE224363T1 (es)
AU (1) AU727900B2 (es)
BG (1) BG63938B1 (es)
BR (1) BR9712816A (es)
CA (1) CA2262566C (es)
CO (1) CO4900032A1 (es)
CZ (1) CZ297252B6 (es)
DE (3) DE19636689A1 (es)
DK (1) DK0929516T3 (es)
EA (1) EA003245B1 (es)
EE (1) EE04431B1 (es)
ES (1) ES2184131T3 (es)
HK (1) HK1020564A1 (es)
HU (1) HUP9904367A3 (es)
IL (1) IL128144A (es)
NO (1) NO312239B1 (es)
NZ (1) NZ334895A (es)
PL (1) PL188012B1 (es)
PT (1) PT929516E (es)
SK (1) SK282432B6 (es)
TR (1) TR199900501T2 (es)
TW (1) TW378200B (es)
UA (1) UA60315C2 (es)
WO (1) WO1998011062A1 (es)
ZA (1) ZA978045B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID29066A (id) * 1998-12-14 2001-07-26 Hoffmann La Roche Turunan fenilglisina
DE19948428A1 (de) * 1999-10-07 2001-04-12 Boehringer Ingelheim Pharma Neuer LTB¶4¶-Antagonist, Verfahren zu dessen Herstellung und dessen Verwendung als Arzneimittel
US6291531B1 (en) * 1999-10-07 2001-09-18 Boehringer Ingelheim Pharma Kg LTB4 antagonist, processes for the preparation thereof and its use as a pharmaceutical composition
US6528491B2 (en) 2000-10-24 2003-03-04 Boehringer Ingelheim Pharma Kg Pyranoside derivatives
DE10052658A1 (de) * 2000-10-24 2002-05-02 Boehringer Ingelheim Pharma Neue Pyranosidderivate
DE10052333A1 (de) * 2000-10-24 2002-05-02 Boehringer Ingelheim Pharma Neue Sulfooxybenzamide
US6489359B2 (en) 2000-10-24 2002-12-03 Boehringer Ingelheim Pharma Kg Sulphoxybenzamides
US7776315B2 (en) * 2000-10-31 2010-08-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and additional active ingredients
US6608054B2 (en) * 2001-03-20 2003-08-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics and endothelin antagonists
AU4239302A (en) * 2001-06-28 2003-01-02 Pfizer Products Inc. Benzoic acid substituted benzopyrans for the treatment of atherosclerosis
US20030119901A1 (en) * 2001-07-14 2003-06-26 Boehringer Ingelheim Pharma Kg Pharmaceutical formulation containing an LTB4 antagonist
NZ530973A (en) * 2001-07-14 2006-07-28 Boehringer Ingelheim Pharma Pharmaceutical formulation containing an LTB4 antagonist
EP1420773A1 (en) * 2001-08-31 2004-05-26 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
DE10213350A1 (de) * 2002-03-26 2003-10-16 Boehringer Ingelheim Pharma Verwendung von LTB¶4¶Antagonisten in der Tiermedizin
US6921752B2 (en) * 2002-03-26 2005-07-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of LTB4 antagonists in veterinary medicine
RS20050390A (en) * 2002-11-26 2008-04-04 Boehringer Ingelheim Pharma Gmbh. & Co.Kg., Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox 1/2 inhibitor
US7262223B2 (en) * 2004-01-23 2007-08-28 Neurochem (International) Limited Amidine derivatives for treating amyloidosis
AU2005260328B2 (en) * 2004-07-05 2009-10-01 Dong Wha Pharmaceutical Co., Ltd. Composition for the prevention and treatment of allergic inflammatory disease
KR20060017929A (ko) * 2004-08-04 2006-02-28 동화약품공업주식회사 티아졸 유도체가 치환된 신규한 벤즈아미딘 유도체, 그의제조방법 및 이를 유효성분으로 하는 약학 조성물
US8679288B2 (en) * 2008-06-09 2014-03-25 Lam Research Corporation Showerhead electrode assemblies for plasma processing apparatuses
CN106831611B (zh) * 2017-01-23 2019-06-21 北京化工大学 一种偕胺肟类化合物及其在制备抑制癌细胞增殖药的应用
EP3623368A4 (en) 2017-05-12 2021-04-07 Riken CLASS A GPCR BINDING COMPOUND MODIFIER
CA3113820A1 (en) * 2018-09-24 2020-04-02 The University Of British Columbia Modulation of granzyme k activity in the treatment of skin conditions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4102024A1 (de) * 1991-01-24 1992-07-30 Thomae Gmbh Dr K Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
EP0518818A3 (en) * 1991-06-11 1993-04-28 Ciba-Geigy Ag Arylethers, their manufacture and use as medicament
US5246965A (en) 1991-06-11 1993-09-21 Ciba-Geigy Arylethers, their manufacture and methods of treatment
DK0902013T3 (da) * 1992-02-05 2002-03-25 Boehringer Ingelheim Pharma Hidtil ukendte amidinderivater, deres fremstilling og anvendelse som lægemidler med LTB4-antagonistisk virkning
DE4219158A1 (de) 1992-06-11 1993-12-16 Thomae Gmbh Dr K Biphenylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE4424713A1 (de) * 1994-07-13 1996-01-18 Boehringer Ingelheim Kg Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe
DE4424714A1 (de) * 1994-07-13 1996-01-18 Boehringer Ingelheim Kg Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff
DE19546452A1 (de) 1995-12-13 1997-06-19 Boehringer Ingelheim Kg Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
NO312239B1 (no) 2002-04-15
CZ82299A3 (cs) 1999-09-15
US6265612B1 (en) 2001-07-24
US6197824B1 (en) 2001-03-06
HK1020564A1 (en) 2000-05-12
JP4288299B2 (ja) 2009-07-01
NZ334895A (en) 2000-09-29
PL188012B1 (pl) 2004-11-30
CA2262566A1 (en) 1998-03-19
DK0929516T3 (da) 2003-01-13
ZA978045B (en) 1998-03-10
ES2184131T3 (es) 2003-04-01
DE59708278D1 (de) 2002-10-24
JP2008266333A (ja) 2008-11-06
SK29699A3 (en) 2000-03-13
SK282432B6 (sk) 2002-02-05
AU4383897A (en) 1998-04-02
JP2001504087A (ja) 2001-03-27
CA2262566C (en) 2006-07-11
JP4150427B2 (ja) 2008-09-17
CZ297252B6 (cs) 2006-10-11
TR199900501T2 (xx) 1999-07-21
EP0929516A1 (de) 1999-07-21
BR9712816A (pt) 1999-11-23
ATE224363T1 (de) 2002-10-15
KR20000036005A (ko) 2000-06-26
WO1998011062A1 (de) 1998-03-19
CN1104412C (zh) 2003-04-02
DE19636689A1 (de) 1998-03-12
PL332136A1 (en) 1999-08-30
EE04431B1 (et) 2005-02-15
NO991131D0 (no) 1999-03-09
EP1203764B1 (de) 2004-05-12
IL128144A0 (en) 1999-11-30
BG103219A (en) 1999-10-29
PT929516E (pt) 2003-01-31
AU727900B2 (en) 2001-01-04
EA199900279A1 (ru) 1999-08-26
EP0929516B1 (de) 2002-09-18
EA003245B1 (ru) 2003-02-27
AR009741A1 (es) 2000-05-03
HUP9904367A2 (hu) 2000-05-28
EE9900086A (et) 1999-10-15
ATE266630T1 (de) 2004-05-15
UA60315C2 (uk) 2003-10-15
NO991131L (no) 1999-03-09
CN1230174A (zh) 1999-09-29
TW378200B (en) 2000-01-01
EP1203764A1 (de) 2002-05-08
IL128144A (en) 2004-07-25
BG63938B1 (bg) 2003-07-31
DE59711625D1 (de) 2004-06-17
HUP9904367A3 (en) 2001-11-28

Similar Documents

Publication Publication Date Title
CO4900032A1 (es) Nuevos derivados de benzamidina
CO5650253A2 (es) Piperazina con grupo fenilo or-sustituido y su uso como inhibidores de glyt1
AR011101A1 (es) Compuesto derivado de acidos arilsulfonilaminohidroxiamicos y composicion farmaceutica que lo contiene
CO5540391A2 (es) Nuevas quinazolinonas espirocondensadas y su uso como inhibi dores de la fosfodiesterasa
CO5550398A2 (es) 7-aminotriazolpirimidinas, proceso e intermedios para su preparacion, composiciones que las comprenden y su uso para controlar hongos dañinos
AR076896A2 (es) Un metodo para inhibir la polimerizacion prematura de monomeros etilenicamente insaturados
CO5640041A2 (es) Un inhibidor de pde4 y un agente anticolinergico en combinacion para tratar enfermedades obstructivas de vias respiratorias
AR006640A1 (es) Procedimiento para la preparacion de una sal de magnesio de un sulfinil-heterociclo substituido
AR017111A1 (es) Composiciones detergentes para el lavado de ropa con polimeros a base de aminas lineales para proporcionar beneficios en cuanto a aspecto exterior eintegridad a las telas lavadas con las mismas
CO5271658A1 (es) Antagonistas del factor liberador de corticotropina
ECSP034475A (es) Derivados de 4-fenil-piridin como antagonistas del receptor de neuroquinina-1
CO4970728A1 (es) 2-aminopiridinas que contienen sustituyentes de anillos condensados
PE20030039A1 (es) Derivados de indol con afinidad por el receptor 5-ht6
AR010331A1 (es) Compuestos derivados de 6-fenilpiridil-2-amina utiles como inhibidores nos, composiciones farmaceuticas que comprenden dichos compuestos, y metodosde tratamiento utilizando dichos compuestos.
PE20212302A1 (es) Inhibidores de apol1 y sus metodos de uso
AR056838A1 (es) Derivados de 1,2,5-tiadiazol
ES2039242T3 (es) Un procedimiento para la preparacion de nuevos derivados de piperidina.
ES2260933T3 (es) Derivados del acido de tiazolina.
AR048567A1 (es) Derivados de benzoxazinona, su preparacion y composiciones farmaceuticas.
AR037907A1 (es) Derivados de azaindolilalquilamina como ligandos de 5-hidroxitriptamina-6
CO4700460A1 (es) 5,6-DIHIDRO-9H-PIRAZOL[3,4-c]-1,2,4-TRIAZOL[4,3-a] PIRIDINAS TRICICLICAS
AR056025A1 (es) Compuestos de imidazol sustituidos como inhibidores de ksp
CO5590924A2 (es) Derivados de indolilalquilamina como ligandos de 5- hidroxitriptamina-6
CO4810374A1 (es) Nueva utilizacion de compuestos para actividad anti- pruritica
CO5011117A1 (es) 1,2,3,4,5,6-hexahidro-2,6-metano-3-benzazocin-10-oles sustituidos y procedimiento para su preparacion .